[Federal Register Volume 59, Number 176 (Tuesday, September 13, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-22600]


[[Page Unknown]]

[Federal Register: September 13, 1994]


-----------------------------------------------------------------------


DEPARTMENT OF JUSTICE
 

Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.43(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on August 15, 1994, Eli Lilly 
Industries, Inc., Chemical Plant, Kilometer 146.7, State Road 2, 
Mayaguez, Puerto Rico 00680, made application to the Drug Enforcement 
Administration (DEA) for registration as a bulk manufacturer of the 
Schedule II controlled substance Dextropropoxyphene, bulk (non-dosage 
forms) (9273).
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the above application and may also file a written 
request for a hearing thereon in accordance with 21 CFR 1301.54 and in 
the form prescribed by 21 CFR 1316.47.
    Any such comments, objections, or requests for a hearing may be 
addressed to the Deputy Assistant Administrator, Office of Diversion 
Control, Drug Enforcement Administration, United States Department of 
Justice, Washington, D.C. 20537, Attention: DEA Federal Register 
Representative (CCR), and must be filed no later than October 13, 1994.

    Dated: September 6, 1994.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 94-22600 Filed 9-12-94; 8:45 am]
BILLING CODE 4410-09-M